- Home
- SNV vs ARWR Comparison
SNV vs ARWR Comparison
Compare SNV & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNV
- ARWR
- Stock Information
- Founded
- SNV 1888
- ARWR 2003
- Country
- SNV United States
- ARWR United States
- Employees
- SNV N/A
- ARWR N/A
- Industry
- SNV Major Banks
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- SNV Finance
- ARWR Health Care
- Exchange
- SNV Nasdaq
- ARWR Nasdaq
- Market Cap
- SNV 6.2B
- ARWR 5.9B
- IPO Year
- SNV N/A
- ARWR 1993
- Fundamental
- Price
- SNV $45.24
- ARWR $39.23
- Analyst Decision
- SNV Buy
- ARWR Strong Buy
- Analyst Count
- SNV 18
- ARWR 8
- Target Price
- SNV $58.50
- ARWR $47.75
- AVG Volume (30 Days)
- SNV 1.4M
- ARWR 1.6M
- Earning Date
- SNV 10-15-2025
- ARWR 11-25-2025
- Dividend Yield
- SNV 3.45%
- ARWR N/A
- EPS Growth
- SNV 143.15
- ARWR N/A
- EPS
- SNV 5.35
- ARWR N/A
- Revenue
- SNV $2,291,796,000.00
- ARWR $572,976,000.00
- Revenue This Year
- SNV $30.36
- ARWR $21,287.22
- Revenue Next Year
- SNV $4.80
- ARWR N/A
- P/E Ratio
- SNV $8.44
- ARWR N/A
- Revenue Growth
- SNV 31.11
- ARWR 2816.20
- 52 Week Low
- SNV $35.94
- ARWR $9.57
- 52 Week High
- SNV $61.06
- ARWR $43.69
- Technical
- Relative Strength Index (RSI)
- SNV 44.35
- ARWR 54.82
- Support Level
- SNV $43.59
- ARWR $37.56
- Resistance Level
- SNV $45.70
- ARWR $40.94
- Average True Range (ATR)
- SNV 1.07
- ARWR 2.11
- MACD
- SNV 0.15
- ARWR -0.38
- Stochastic Oscillator
- SNV 55.29
- ARWR 32.32
About SNV Synovus Financial Corp.
Synovus Financial Corp provides commercial and consumer banking in addition to a full suite of specialized products & services such as private banking, treasury management, wealth management, mortgage services, premium finance, asset-based lending, structured lending, capital markets, & international banking to clients through the wholly-owned subsidiary bank, Synovus Bank, and other offices in Alabama, Florida, Georgia, South Carolina, and Tennessee. It has four segments Wholesale Banking, Community Banking, Consumer Banking, and Financial Management Services, out of which the majority is from the Wholesale banking segment.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.